Home > M&A deals 2014 > EPIRUS Biopharmaceuticals, Inc. merges with Zalicus, Inc.
Merger · Life Science · July 2014

EPIRUS Biopharmaceuticals, Inc. merges with Zalicus, Inc.

On July 15, 2014, EPIRUS Biopharmaceuticals, Inc. merged with Zalicus, Inc., a life science company in Massachusetts, United States.

Deal at a glance

AnnouncedJuly 15, 2014 TypeMerger TargetZalicus, Inc. Buyer EPIRUS Biopharmaceuticals, Inc. SectorLife Science LocationMassachusetts, United States ValueNot disclosed

Target company

Zalicus, Inc.
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

EPIRUS Biopharmaceuticals, Inc.
Company · 3 deals on record
  • 1st transaction in life science
  • 1st transaction in United States
3deals, all time
1in this sector
2015latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Zalicus, Inc.?EPIRUS Biopharmaceuticals, Inc. merged with Zalicus, Inc. on July 15, 2014.

What type of deal was it?It was a merger in the life science sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).